THURSDAY
Adaptimmune Therapeutics PLC Sponsored ADR
SCoRE: 58
LAST PRICE - AT THE CLOSE
ADAPY is DOWN -23% since the begininning of the year
ADAPY is UP 37% ABOVE 20 day SMA
ADAPY is DOWN N/A% BELOW 200 day SMA
PROFITABLE: NO
EPS: $-0.1163
EARNINGS MOMENTUM: N/A
N/A INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00
 |
THE STOCK IS 71.4% AWAY FROM ALL-TIME HIGHS OF $0.07 |
 |
ADAPY IS DOWN -23% SINCE THE BEGINNING OF THE YEAR |
 |
ADAPY IS DOWN -64% OVER THE PAST 12 MONTHS |
 |
ADAPY IS UP 32% OVER THE PAST 1 MONTH |
 |
0% OF ALL ADAPY INVESTORS ARE BETTING AGAINST ADAPY |
 |
NUM INVESTORS SHORT ADAPY HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|
 |
ADAPY moved up 0 in the previous minute |
 |
ADAPY is up 0 over the last hour |
 |
ADAPY is up 98% over the last 5 days |
 |
ADAPY is 26.9 above its 8 day SMA |
| $0.02 | DAY |
$0.02 |
| $0.00 |   PREVIOUS DAY |
$0.02 |
| $0.00 | WEEK |
$0.02 |
| $0.00 | MONTH |
$0.03 |
| $0.00 |  YEAR |
$0.07 |
ADAPY is mentioned N/A less than normal on 
ADAPY is mentioned N/A times in an average day on 
